{
    "clinical_study": {
        "@rank": "60383", 
        "acronym": "EXPEL", 
        "arm_group": [
            {
                "arm_group_label": "Stent", 
                "arm_group_type": "Active Comparator", 
                "description": "drug eluting stent (Resolute)"
            }, 
            {
                "arm_group_label": "drug eluting balloon", 
                "arm_group_type": "Experimental", 
                "description": "drug eluting balloon (Elutax)"
            }
        ], 
        "brief_summary": {
            "textblock": "A randomised open-label pilot study to assess the safety and efficacy of treatment with a\n      drug eluting balloon alone in coronary de novo lesions). Elective patients requiring PCI to\n      coronary de novo lesions in vessels 2.5 mm - 4.0 mm."
        }, 
        "brief_title": "The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Stable Angina", 
            "Coronary Stenosis"
        ], 
        "condition_browse": {
            "mesh_term": "Coronary Stenosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient \u2265 18years old\n\n          -  Stable angina symptoms\n\n          -  Elective treatment to coronary lesion\n\n          -  Reference vessel diameters of \u2265 2.5mm and \u2264 4.0 mm on visual inspection\n\n        Exclusion Criteria:\n\n          -  Left main stem lesion\n\n          -  Bifurcation lesions\n\n          -  Acute coronary syndrome (UAP, NSTEMI, STEMI)\n\n          -  Cardiogenic shock\n\n          -  Chronic total occlusion\n\n          -  Additional lesions requiring PCI\n\n          -  Platelet count \u2264 50 x 109/mm3\n\n          -  Left ventricular ejection fraction \u2264 30%\n\n          -  Patient life expectancy less than 12 months\n\n          -  Known allergies to aspirin, clopidogrel, prasugrel, heparin, stainless steel,\n             intravenous contrast (severe), or paclitaxel\n\n          -  Participation in another investigational drug or device study\n\n          -  Patient unable to give informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "July 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899235", 
            "org_study_id": "N-20110015"
        }, 
        "intervention": [
            {
                "arm_group_label": "drug eluting balloon", 
                "intervention_name": "drug eluting balloon", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Stent", 
                "intervention_name": "drug eluting stent", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Paclitaxel"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 15, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aalborg", 
                    "country": "Denmark", 
                    "zip": "9000"
                }, 
                "name": "Aalborg University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "official_title": "The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "Denmark: Ethics Committee", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Major adverse cardiac events", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899235"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aalborg Universityhospital", 
            "investigator_full_name": "Svend Eggert Jensen", 
            "investigator_title": "Associate professor, MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Aalborg Universityhospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Aachen Resonance, Aachen, Germany", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Aalborg Universityhospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014", 
        "why_stopped": "Slow recruitment"
    }
}